RVTY
Get informed when a big investor buys or sells
+ FollowOvervalued by 45.1% based on the discounted cash flow analysis.
| Market cap | $14.37 Billion |
|---|---|
| Enterprise Value | $16.69 Billion |
| Dividend Yield | $0.28 (0.22%) |
| Earnings per Share | $2.08 |
| Beta | 1.07 |
| Outstanding Shares | 111,746,000 |
| P/E Ratio | 61.33 |
|---|---|
| PEG | -1554.89 |
| Price to Sales | 5.02 |
| Price to Book Ratio | 2.04 |
| Enterprise Value to Revenue | 5.73 |
| Enterprise Value to EBIT | 46.88 |
| Enterprise Value to Net Income | 70 |
| Total Debt to Enterprise | 0.2 |
| Debt to Equity | 0.46 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.4904▼ 1150.33% |
|---|---|
| Total Calls | 78,500▲ 23.10% |
| Total Puts | 38,500▼ 94.97% |
Holdings and activity of institutional investors.
| Ownership % | 115.53%▲ 12.30% |
|---|---|
| Total Invested | $12.92B▲ 27.68% |
| Investors Holding | 551▲ 40.00% |
No data
PerkinElmer enables scientists, researchers, and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, the company delivers unique solutions to ser...